Skip to main content
FOUNDAYO .8 mg/1 tablet, film coated by Eli Lilly and Company
FOUNDAYO, .8 mg/1, tablet, film coated Drug class: GLP-1 Receptor Agonist. Available on prescription only. Listed by Eli Lilly and Company.
Prescription only

FOUNDAYO

orforglipron

Listed by Eli Lilly and Company

Strength
.8 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
GLP-1 Receptor Agonist

What it contains

  • Orforglipron Calcium .8 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class GLP-1 Receptor Agonist
Approval route NDA — original brand approval
NDC code 0002-4178
FDA application NDA220934
RxNorm concept 2739844
Package sizes listed 2
Marketed since April 2026

Other products containing Orforglipron

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

FOUNDAYO

orforglipron

Strength
17.2 mg/1
Form
Tablet, Film Coated
Class
GLP-1 Receptor Agonist
Rx only

Eli Lilly and Company

Not stocked by us — reference only

FOUNDAYO

orforglipron

Strength
14.5 mg/1
Form
Tablet, Film Coated
Class
GLP-1 Receptor Agonist
Rx only

Eli Lilly and Company

Not stocked by us — reference only

FOUNDAYO

orforglipron

Strength
9 mg/1
Form
Tablet, Film Coated
Class
GLP-1 Receptor Agonist
Rx only

Eli Lilly and Company

Not stocked by us — reference only

FOUNDAYO

orforglipron

Strength
5.5 mg/1
Form
Tablet, Film Coated
Class
GLP-1 Receptor Agonist
Rx only

Eli Lilly and Company

Not stocked by us — reference only

FOUNDAYO

orforglipron

Strength
2.5 mg/1
Form
Tablet, Film Coated
Class
GLP-1 Receptor Agonist
Rx only

Eli Lilly and Company

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.